Category: Generics Drugs
North America Generics Drugs
-
Canada Generics Market Summary, Competitive Analysis and Forecast to 2027
... 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined ... Read More
-
Mexico Generics Market Summary, Competitive Analysis and Forecast to 2027
... 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined ... Read More
-
North America Generics Market Summary, Competitive Analysis and Forecast to 2027
... forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug ... Read More
-
United States Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 47.0 Billion by 2028, exhibiting a growth rate (CAGR) of 9.6% during 2023-2028. Specialty generic drugs are the generic versions of specialty branded drugs once they lose patent protection. These drugs ... Read More
-
North America Specialty Generics Market Size, Share & Industry Trends Analysis Report
... Forecast, 2023 - 2030 The North America Specialty Generics Market would witness market growth of 9.0% CAGR during the forecast period (2023-2030). The complex or high-end specialty generics are generic equivalents of drugs. However, they ... Read More
-
US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 32.7 Billion by 2028, exhibiting a growth rate (CAGR) of 9.8% during 2023-2028. A generic injectable refers to a bioequivalent of the branded pharmaceutical needle with the same active ingredients and therapeutic effects. ... Read More
-
Global HIV Treatment Market: Analysis By Product (Atripla, Biktarvy, Descovy, Genovya, Odefsey, Truvada, Sunlenca (Lenacapavir), Dovato, Juluca, Tivicay, Triumeq, Cabenuva, VH184, Capsid, bNAbs, Islatravir, and Generics), By Region (The US, and EU + ROW) Size and Trends with Impact of COVID-19 and Forecast up to 2030
... and Trends with Impact of COVID-19 and Forecast up to 2030 The global HIV treatment market in 2022 stood at US$22.38 billion, and is likely to reach US$25.49 billion by 2030. HIV treatment, also known ... Read More
-
United States Pharmaceutical Logistics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... Highlights Transportation problems were making it hard to distribute COVID-19, which was causing problems in the drug supply chain.Port disruptions, quarantined personnel, and labor shortages caused by lockdowns were all factors. Furthermore, COVID-19 slowed the ... Read More
-
United States Generic Drugs Market, Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis
... grow at a CAGR of 6.39% from 2022 to 2028. The pharmaceutical industry is vital for global healthcare, but it is important to distinguish between factors driving cost increases and those generating savings. Specialty drugs, ... Read More
-
US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 110.7 Billion by 2028, exhibiting a growth rate (CAGR) of 4% during 2023-2028. Generics are off-patented drugs that are bioequivalent to branded medications in terms of dosage, strength, quality, form, effect, intended use, side effects, ... Read More
-
North America Pulmonary Arterial Hypertension Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Drugs [Endothelin Receptor Antagonists (ERAs), Prostacyclin and Prostacyclin Analogs, sGC Stimulators, and pde-5 Dipsticks], Type (Branded and Generics), Route of Administration (Oral, Intravenous/Subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies)
... Route of Administration (Oral, Intravenous/Subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies) The North America pulmonary arterial hypertension market is expected to grow from US$ 3,147.76 million in ... Read More
-
North America Branded Generics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics & Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)
... Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others) The branded generics market in North ... Read More
-
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028, NAIC 325412
... countless hours of research. Key Findings: Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.) to reach $263,595,616,271 million by 2029. Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry, including Average EBITDA, Operating Ratios and Sales per ... Read More
-
North America Inhalation and Nasal Spray Generic Drugs Market Size, Share & Industry Trends Analysis Report By End-user, By Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis), By Distribution Channel, By Demographics, By
... and Growth Forecast, 2022 – 2028 The North America Inhalation and Nasal Spray Generic Drugs Market would witness market growth of 8.0% CAGR during the forecast period (2022-2028). Inhalation therapy involves dispersing medications into the ... Read More
-
Prebiotics for Dietary Supplements Market, by Ingredient Type (Galacto-oligosaccharides (GOS), Fructo-oligosaccharides (FOS), Xylooligosaccharides (XOS), Isomaltooligosaccharides (IMO) and Human milk oligosaccharides (HMO)), by Source (Plant (Including Botanicals) and Animal), by Distribution Channel (B2B (Generic) (Broker and Direct (supplier to client)), B2C (Branded) (Pharmacies, Specialty Stores, and Hypermarket and supermarket)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Direct (supplier to client)), B2C (Branded) (Pharmacies, Specialty Stores, and Hypermarket and supermarket)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
Top 5 Emerging Countries Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
... to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights These countries contributed $112,996.1 million to the global generics industry ... Read More
-
North America (NAFTA) Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
... The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The North American Free Trade Agreement (NAFTA) is a trade agreement between ... Read More
-
G8 Countries Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
... profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The G8 countries contributed $157,809.2 million in 2021 to the global generics industry, ... Read More
-
Fibromyalgia Treatment Market, by Drug Class (Antidepressants (Milnacipran (Savella and Other Generics), Duloxetine (Cymbalta and Other Generics), and Others), Antiepileptics (Pregabalin (Lyrica and Other Generics), and Others), Muscle Relaxants, Analgesics, and Others (Including Pipeline Drugs)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Fibromyalgia is ... Read More
-
North America Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
... to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is ... Read More
-
Mexico Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
... also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy ... Read More
-
Canada Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
... descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy of an ... Read More
-
United States of America (USA) Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
... volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, ... Read More
-
Global Generic Drugs Market; By Product Type (Simple Generics, Super Generics, and Biosimilars); By Route of Administration (Oral, Topical, Injectable, and Others); By Application (Cardiovascular Products, Anti-infective Drugs, Central Nervous System Drugs, Anti-cancer Drugs, Respiratory Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028 Generic Drugs Market ... Read More
-
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Metrics, Benchmarks Against Averages and Top Companies Within Its Industry, and Revenue Forecasts to 2028, NAIC 325412
... numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.) to reach $351,746 million by 2028. Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry ... Read More
Research Assistance
